Joseph Califano

8PUBLICATIONS
38CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 17, 2026
CD47 blockade (ALX301) enhances immunoradiotherapy response in HPV negative head and neck squamous cell carcinoma.

Abdula Monther, Riyam Al-Msari, Robert Saddawi-Konefka

|Aug 21, 2025
HPV E5 Mediates Resistance to Chemotherapy and Radiation by Promoting a Stem Cell-Like Phenotype in Head and Neck Squamous Cell Carcinoma.

Souvick Roy, Sayuri Miyauchi, Riley N Jones

|Jul 17, 2025
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy.

Robert Saddawi-Konefka, Riyam Al Msari, Shiqi Tang

|Mar 27, 2025
Inhibition of human-HPV hybrid ecDNA enhancers reduces oncogene expression and tumor growth in oropharyngeal cancer.

Takuya Nakagawa, Jens Luebeck, Kaiyuan Zhu

|Feb 26, 2025
So Close, and Yet… Plasma HPV DNA Detection of Recurrent HPV Oropharynx Cancer.

Joseph A Califano

|Mar 20, 2023
Patterns of Lymph Node Metastasis in Parotid Cancer and Implications for Extent of Neck Dissection.

Rohith S Voora, Bharat Panuganti, Joseph Califano

Pageof 2

Frequent Collaborators

3 joint publications

Riley N Jones

2 joint publications

Loren K Mell

2 joint publications

Rohith S Voora

2 joint publications

Sayuri Miyauchi